White Papers

  1. 2021 Completed Trials: Green Shoots Of COVID-19 Recovery Become Apparent 5/19/2022

    The COVID-19 pandemic continued to reshape the clinical trials landscape in 2021. Trialtrove recorded 4,109 industry-sponsored clinical trials from Phase I through to Phase III/IV that either reached completed status or reported primary endpoints, an 8.8% annual increase.

  2. Patient-Centric Oral Solid Dose Formulation: Improving Access And Value Across The Product Lifecycle 5/17/2022

    Gain insight into the systematic application of patient centricity to the design of OSD products.

  3. mRNA Vaccine Development: Planning, Workflow, And Supply Chain Success 5/17/2022

    A review of insights derived from the development of mRNA-based COVID-19 vaccines and how they can be applied to accelerate progress in the manufacture of vaccines and therapeutics moving forward.

  4. Continuous Manufacturing And Late-Phase Strategy: The Time Is Now 5/17/2022

    Explore recent progress in continuous manufacturing and guidance for answering key questions related to implementation of continuous processing for late-phase development.                             

  5. The Changing Landscape Of Oncology Drug Development: Bringing Novel Lifesaving Therapies To Patients 5/17/2022

    This white paper provides strategic guidance for successfully navigating complexities, such as unique formulation and handling requirements, novel trial designs and the supply chain implications, and regulatory and clinical strategies to support product approvals.

  6. Direct-To-Patient Supply: Industry Perception And Future Trends 5/5/2022

    234 individuals involved in clinical supply and operations were surveyed to better understand sponsors’ perspectives on DTP distribution of clinical supplies and interest in using it in their studies.

  7. Accelerating Study Start Up Through An Electronic Clinical Outcome Assessment (eCOA) Library 5/2/2022

    Dive into how the shift to patient reported outcomes has made Clinical Outcome Assessments (COAs) an increasingly necessary and often required tool in the clinical research landscape.

  8. The Urgent Need To Demonstrate Value In Real Time 5/2/2022

    Systematic literature reviews (SLRs) are essential for proving product value, yet very often, the speed of scientific discovery outpaces the ability of researchers to integrate new insights into existing SLRs. Discover a new approach that ensures the most recent science is quickly incorporated into industry research programs.

  9. A New Approach To Faster Electronic Clinical Outcome Assessment (eCOA) Development 5/2/2022

    The value of eCOA tools is undisputed, but using a waterfall methodology of software delivery is highly inefficient. Explore how a more agile approach to eCOA development can produce a fully functional eCOA in a day.

  10. Direct-From-Patient Data Capture With eCOA 5/2/2022

    Learn how an eCOA tool can provide patients a chance to be heard while giving sponsors quantitative and qualitative data to track the efficacy of a treatment.